Loading...

Prakash Deedwania, MD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentDean's Office
AddressUCSF Fresno MEP
Fresno CA 93701
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Lam PH, Dooley DJ, Inampudi C, Arundel C, Fonarow GC, Butler J, Wu WC, Blackman MR, Anker MS, Deedwania P, White M, Prabhu SD, Morgan CJ, Love TE, Aronow WS, Allman RM, Ahmed A. Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone. Int J Cardiol. 2016 Nov 4. PMID: 27866868.
      View in: PubMed
    2. Srikanth S, Deedwania P. Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome. Curr Hypertens Rep. 2016 Oct; 18(10):76. PMID: 27730495.
      View in: PubMed
    3. Deedwania PC, Pedersen TR, DeMicco DA, Breazna A, Betteridge DJ, Hitman GA, Durrington P, Neil A. Differing predictive relationships between baseline LDL-C, systolic blood pressure, and cardiovascular outcomes. Int J Cardiol. 2016 Nov 1; 222:548-56. PMID: 27513651.
      View in: PubMed
    4. Deedwania P, Acharya T. Mechanical Circulatory Support and Rationale for Future Research-Reply. JAMA Intern Med. 2016 May 1; 176(5):715-6. PMID: 27136339.
      View in: PubMed
    5. Shepherd J, Breazna A, Deedwania PC, LaRosa JC, Wenger NK, Messig M, Wilson DJ. Relation Between Change in Renal Function and Cardiovascular Outcomes in Atorvastatin-Treated Patients (from the Treating to New Targets [TNT] Study). Am J Cardiol. 2016 Apr 15; 117(8):1199-205. PMID: 26940556.
      View in: PubMed
    6. Deedwania PC, Shepherd J, Breazna A, DeMicco DA. Effect of high-dose atorvastatin on the cardiovascular risk associated with individual components of metabolic syndrome: a subanalysis of the Treating to New Targets (TNT) study. Diabetes Obes Metab. 2016 Jan; 18(1):56-63. PMID: 26434404.
      View in: PubMed
    7. Deedwania P, Acharya T. Is Increased Use of Mechanical Circulatory Support Devices Justified?: A Cause for Concern. JAMA Intern Med. 2015 Dec 1; 175(12):1982-3. PMID: 26523417.
      View in: PubMed
    8. Deedwania PC, Stone PH, Fayyad RS, Laskey RE, Wilson DJ. Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial. Drugs Aging. 2015 Dec; 32(12):1055-65. PMID: 26625880.
      View in: PubMed
    9. Kiel RG, Deedwania P. The safety and tolerability of beta blockers in heart failure with reduced ejection fraction: is the current underutilization of this evidence-based therapy justified? Expert Opin Drug Saf. 2015 Dec; 14(12):1855-63. PMID: 26488593.
      View in: PubMed
    10. Acharya T, Tringali S, Bhullar M, Nalbandyan M, Ilineni VK, Carbajal E, Deedwania P. Frequent Atrial Premature Complexes and Their Association With Risk of Atrial Fibrillation. Am J Cardiol. 2015 Dec 15; 116(12):1852-7. PMID: 26611122.
      View in: PubMed
    11. Jacobson TA, Maki KC, Orringer CE, Jones PH, Kris-Etherton P, Sikand G, La Forge R, Daniels SR, Wilson DP, Morris PB, Wild RA, Grundy SM, Daviglus M, Ferdinand KC, Vijayaraghavan K, Deedwania PC, Aberg JA, Liao KP, McKenney JM, Ross JL, Braun LT, Ito MK, Bays HE, Brown WV. National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. J Clin Lipidol. 2015 Nov-Dec; 9(6 Suppl):S1-S122.e1. PMID: 26699442.
      View in: PubMed
    12. Anker SD, Kosiborod M, Zannad F, Piña IL, McCullough PA, Filippatos G, van der Meer P, Ponikowski P, Rasmussen HS, Lavin PT, Singh B, Yang A, Deedwania P. Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial. Eur J Heart Fail. 2015 Oct; 17(10):1050-6. PMID: 26011677.
      View in: PubMed
    13. Ahmed AA, Patel K, Nyaku MA, Kheirbek RE, Bittner V, Fonarow GC, Filippatos GS, Morgan CJ, Aban IB, Mujib M, Desai RV, Allman RM, White M, Deedwania P, Howard G, Bonow RO, Fletcher RD, Aronow WS, Ahmed A. Risk of Heart Failure and Death After Prolonged Smoking Cessation: Role of Amount and Duration of Prior Smoking. Circ Heart Fail. 2015 Jul; 8(4):694-701. PMID: 26038535.
      View in: PubMed
    14. Gupta R, Sharma KK, Gupta BK, Gupta A, Saboo B, Maheshwari A, Mahanta T, Deedwania PC. Geographic epidemiology of cardiometabolic risk factors in middle class urban residents in India: cross-sectional study. J Glob Health. 2015 Jun; 5(1):010411. PMID: 25969733; PMCID: PMC4416330.
    15. Aftab W, Gazallo J, Motabar A, Varadrajan P, Deedwania PC, Pai RG. Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation. Int J Angiol. 2015 Jun; 24(2):105-12. PMID: 26060381; PMCID: PMC4452604 [Available on 06/01/16].
    16. Acharya T, Deedwania P. An evidence-based review of edoxaban and its role in stroke prevention in patients with nonvalvular atrial fibrillation. Core Evid. 2015; 10:63-73. PMID: 26019695; PMCID: PMC4422295.
    17. Deedwania P. Gaps in guideline implementation: a cause for concern, time for action. J Am Coll Cardiol. 2015 Jan 27; 65(3):278-80. PMID: 25614425.
      View in: PubMed
    18. Gupta R, Sharma KK, Gupta BK, Gupta A, Gupta RR, Deedwania PC. Educational status-related disparities in awareness, treatment and control of cardiovascular risk factors in India. Heart Asia. 2015; 7(1):1-6. PMID: 27326202.
      View in: PubMed
    19. Deedwania PC. Management of Patients With Stable Angina and Type 2 Diabetes. Rev Cardiovasc Med. 2015; 16(2):105-13. PMID: 26198557.
      View in: PubMed
    20. Bhatia V, Bajaj NS, Sanam K, Hashim T, Morgan CJ, Prabhu SD, Fonarow GC, Deedwania P, Butler J, Carson P, Love TE, Kheirbek R, Aronow WS, Anker SD, Waagstein F, Fletcher R, Allman RM, Ahmed A. Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure. Am J Med. 2015 Jul; 128(7):715-21. PMID: 25554369.
      View in: PubMed
    21. Arsenault BJ, Barter P, DeMicco DA, Bao W, Preston GM, LaRosa JC, Grundy SM, Deedwania P, Greten H, Wenger NK, Shepherd J, Waters DD, Kastelein JJ. Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkers. PLoS One. 2014; 9(12):e114519. PMID: 25531109; PMCID: PMC4273994.
    22. Jones LG, Sin MK, Hage FG, Kheirbek RE, Morgan CJ, Zile MR, Wu WC, Deedwania P, Fonarow GC, Aronow WS, Prabhu SD, Fletcher RD, Ahmed A, Allman RM. Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the Veterans Affairs versus other hospitals: insights from the Beta-blocker Evaluation of Survival Trial (BEST). Circ Heart Fail. 2015 Jan; 8(1):17-24. PMID: 25480782; PMCID: PMC4377074 [Available on 01/01/16].
    23. Gupta A, Gupta R, Sharma KK, Lodha S, Achari V, Asirvatham AJ, Bhansali A, Gupta B, Gupta S, Jali MV, Mahanta TG, Maheshwari A, Saboo B, Singh J, Deedwania PC. Prevalence of diabetes and cardiovascular risk factors in middle-class urban participants in India. BMJ Open Diabetes Res Care. 2014; 2(1):e000048. PMID: 25489485; PMCID: PMC4256307.
    24. Kumbhani DJ, Fonarow GC, Cannon CP, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Deedwania P, Grau-Sepulveda M, Schwamm LH, Bhatt DL. Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease. Am J Med. 2015 Apr; 128(4):426.e1-9. PMID: 25433302.
      View in: PubMed
    25. Inampudi C, Deedwania P, Fonarow GC, Sanders PW, Aronow WS, Ahmed A. Reply: To PMID 24846806. Am J Cardiol. 2015 Jan 1; 115(1):156. PMID: 25454018.
      View in: PubMed
    26. Böhm M, Reil JC, Deedwania P, Kim JB, Borer JS. Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease. Am J Med. 2015 Mar; 128(3):219-28. PMID: 25447617.
      View in: PubMed
    27. Patel K, Fonarow GC, Ahmed M, Morgan C, Kilgore M, Love TE, Deedwania P, Aronow WS, Anker SD, Ahmed A. Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction. Circ Heart Fail. 2014 Nov; 7(6):945-52. PMID: 25296862.
      View in: PubMed
    28. White M, Patel K, Caldentey G, Deedwania P, Kheirbek R, Fletcher RD, Aban IB, Lo A, Aronow WS, Fonarow GC, Anker SD, Ahmed A. Racial differences in mortality in patients with advanced systolic heart failure: potential role of right ventricular ejection fraction. Int J Cardiol. 2014 Nov 15; 177(1):255-60. PMID: 25499389.
      View in: PubMed
    29. Bajaj NS, Bhatia V, Sanam K, Ather S, Hashim T, Morgan C, Fonarow GC, Nanda NC, Prabhu SD, Adamopoulos C, Kheirbek R, Aronow WS, Fletcher RD, Anker SD, Ahmed A, Deedwania P. Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in community-dwelling older adults. Am J Cardiol. 2014 Sep 15; 114(6):909-13. PMID: 25208562.
      View in: PubMed
    30. Deedwania PC, Gupta R, Sharma KK, Achari V, Gupta B, Maheshwari A, Gupta A. High prevalence of metabolic syndrome among urban subjects in India: a multisite study. Diabetes Metab Syndr. 2014 Jul-Sep; 8(3):156-61. PMID: 25220918.
      View in: PubMed
    31. Inampudi C, Parvataneni S, Morgan CJ, Deedwania P, Fonarow GC, Sanders PW, Prabhu SD, Butler J, Forman DE, Aronow WS, Allman RM, Ahmed A. Spironolactone use and higher hospital readmission for Medicare beneficiaries with heart failure, left ventricular ejection fraction <45%, and estimated glomerular filtration rate <45 ml/min/1.73 m(2.). Am J Cardiol. 2014 Jul 1; 114(1):79-82. PMID: 24846806; PMCID: PMC4169696.
    32. Guptha S, Gupta R, Deedwania P, Bhansali A, Maheshwari A, Gupta A, Gupta B, Saboo B, Singh J, Achari V, Sharma KK. Cholesterol lipoproteins and prevalence of dyslipidemias in urban Asian Indians: a cross sectional study. Indian Heart J. 2014 May-Jun; 66(3):280-8. PMID: 24973832; PMCID: PMC4121768.
    33. Deedwania PC. Statins in chronic kidney disease: cardiovascular risk and kidney function. Postgrad Med. 2014 Jan; 126(1):29-36. PMID: 24393749.
      View in: PubMed
    34. Kiel RG, Deedwania P. Medical treatment of hypertension in patients with heart failure with preserved ejection fraction. Curr Cardiol Rep. 2013 Dec; 15(12):428. PMID: 24162922.
      View in: PubMed
    35. Ahmed A, Bourge RC, Fonarow GC, Patel K, Morgan CJ, Fleg JL, Aban IB, Love TE, Yancy CW, Deedwania P, van Veldhuisen DJ, Filippatos GS, Anker SD, Allman RM. Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure. Am J Med. 2014 Jan; 127(1):61-70. PMID: 24257326; PMCID: PMC3929967.
    36. Bangalore S, Fayyad R, Laskey R, Demicco DA, Deedwania P, Kostis JB, Messerli FH. Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease. Am J Med. 2014 Jan; 127(1):71-81.e1. PMID: 24210549.
      View in: PubMed
    37. Deedwania P. Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure. Drugs. 2013 Sep; 73(14):1569-86. PMID: 24065301; PMCID: PMC3786091.
    38. Bangalore S, Fayyad R, Laskey R, DeMicco D, Deedwania P, Kostis JB, Messerli FH. Lipid lowering in patients with treatment-resistant hypertension: an analysis from the Treating to New Targets (TNT) trial. Eur Heart J. 2014 Jul 14; 35(27):1801-8. PMID: 23990605.
      View in: PubMed
    39. Deedwania P, Patel K, Fonarow GC, Desai RV, Zhang Y, Feller MA, Ovalle F, Love TE, Aban IB, Mujib M, Ahmed MI, Anker SD, Ahmed A. Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort study. Int J Cardiol. 2013 Oct 9; 168(4):3616-22. PMID: 23731526; PMCID: PMC3939803.
    40. Bethel MA, Chacra AR, Deedwania P, Fulcher GR, Holman RR, Jenssen T, Kahn SE, Levitt NS, McMurray JJ, Califf RM, Raptis SA, Thomas L, Sun JL, Haffner SM. A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk. Am J Cardiol. 2013 Jul 15; 112(2):231-7. PMID: 23608615.
      View in: PubMed
    41. Deedwania P. Diabetes, cardiovascular disease, and ethnicity. J Am Coll Cardiol. 2013 Apr 30; 61(17):1787-9. PMID: 23500320.
      View in: PubMed
    42. Deedwania P, Shea J, Chen W, Brener L. Effects of add-on nebivolol on blood pressure and glucose parameters in hypertensive patients with prediabetes. J Clin Hypertens (Greenwich). 2013 Apr; 15(4):270-8. PMID: 23551727.
      View in: PubMed
    43. Deedwania PC. New oral anticoagulants in elderly patients with atrial fibrillation. Am J Med. 2013 Apr; 126(4):289-96. PMID: 23369212.
      View in: PubMed
    44. Gupta R, Deedwania PC, Achari V, Bhansali A, Gupta BK, Gupta A, Mahanta TG, Asirvatham AJ, Gupta S, Maheshwari A, Saboo B, Jali MV, Singh J, Guptha S, Sharma KK. Normotension, prehypertension, and hypertension in urban middle-class subjects in India: prevalence, awareness, treatment, and control. Am J Hypertens. 2013 Jan; 26(1):83-94. PMID: 23382331.
      View in: PubMed
    45. Deedwania PC. Ivabradine in heart failure: hope or hype? Am J Cardiovasc Drugs. 2012 Dec 1; 12(6):357-9. PMID: 23181943.
      View in: PubMed
    46. Deedwania P, Ahmed A. Prediabetes and the risk of diabetes. Lancet. 2012 Oct 6; 380(9849):1225; author reply 1226. PMID: 23040849.
      View in: PubMed
    47. Bangalore S, Steg G, Deedwania P, Crowley K, Eagle KA, Goto S, Ohman EM, Cannon CP, Smith SC, Zeymer U, Hoffman EB, Messerli FH, Bhatt DL. ß-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012 Oct 3; 308(13):1340-9. PMID: 23032550.
      View in: PubMed
    48. Deedwania PC. Heart failure: a common and complex clinical syndrome. Med Clin North Am. 2012 Sep; 96(5):xi-xii. PMID: 22980062.
      View in: PubMed
    49. Deedwania PC, Carbajal E. Evidence-based therapy for heart failure. Med Clin North Am. 2012 Sep; 96(5):915-31. PMID: 22980055.
      View in: PubMed
    50. Rathi S, Deedwania PC. The epidemiology and pathophysiology of heart failure. Med Clin North Am. 2012 Sep; 96(5):881-90. PMID: 22980052.
      View in: PubMed
    51. Gupta R, Deedwania PC, Sharma K, Gupta A, Guptha S, Achari V, Asirvatham AJ, Bhansali A, Gupta B, Gupta S, Jali MV, Mahanta TG, Maheshwari A, Saboo B, Singh J, Gupta R. Association of educational, occupational and socioeconomic status with cardiovascular risk factors in Asian Indians: a cross-sectional study. PLoS One. 2012; 7(8):e44098. PMID: 22952886; PMCID: PMC3430674.
    52. Lardizabal JA, Deedwania PC. Atrial fibrillation in heart failure. Med Clin North Am. 2012 Sep; 96(5):987-1000. PMID: 22980060.
      View in: PubMed
    53. Deedwania P, Huang GW. An evidence-based review of apixaban and its potential in the prevention of stroke in patients with atrial fibrillation. Core Evid. 2012; 7:49-59. PMID: 22826692; PMCID: PMC3402013.
    54. Gupta R, Guptha S, Sharma KK, Gupta A, Deedwania P. Regional variations in cardiovascular risk factors in India: India heart watch. World J Cardiol. 2012 Apr 26; 4(4):112-20. PMID: 22558490; PMCID: PMC3342579.
    55. Deedwania PC, Zappe DH, Egan BM, Purkayastha D, Samuel R, Sowers JR. Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide? J Clin Hypertens (Greenwich). 2012 Jul; 14(7):415-21. PMID: 22747613.
      View in: PubMed
    56. Mora S, Wenger NK, Demicco DA, Breazna A, Boekholdt SM, Arsenault BJ, Deedwania P, Kastelein JJ, Waters DD. Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) study. Circulation. 2012 Apr 24; 125(16):1979-87. PMID: 22461416; PMCID: PMC3338158.
    57. Ho JE, Waters DD, Kean A, Wilson DJ, Demicco DA, Breazna A, Wun CC, Deedwania PC, Khush KK. Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study). Am J Cardiol. 2012 Jun 15; 109(12):1761-6. PMID: 22459310; PMCID: PMC4454417.
    58. Qian F, Ling FS, Deedwania P, Hernandez AF, Fonarow GC, Cannon CP, Peterson ED, Peacock WF, Kaltenbach LA, Laskey WK, Schwamm LH, Bhatt DL. Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association Get With The Guidelines-Coronary Artery Disease program. Circ Cardiovasc Qual Outcomes. 2012 Jan; 5(1):126-33. PMID: 22235068.
      View in: PubMed
    59. Deedwania P, Huang GW. An update on antithrombotic therapy in atrial fibrillation: the role of newer and emergent drugs. Rev Cardiovasc Med. 2012; 13(2-3):e89-104. PMID: 23160166.
      View in: PubMed
    60. Arsenault BJ, Boekholdt SM, Hovingh GK, Hyde CL, DeMicco DA, Chatterjee A, Barter P, Deedwania P, Waters DD, LaRosa JC, Pedersen TR, Kastelein JJ. The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies. Circ Cardiovasc Genet. 2012 Feb 1; 5(1):51-7. PMID: 22135385.
      View in: PubMed
    61. Luke MM, Berger K, Rowland CM, Catanese JJ, Tong CH, Ross DA, Garcia V, Kuhlenbaeumer G, Ringelstein EB, Pullinger CR, Malloy MJ, Deedwania P, Ellis SG, Kane JP, Devlin JJ, Lalouschek W, Mannhalter C. Polymorphisms and noncardioembolic stroke in three case-control studies. Cerebrovasc Dis. 2012; 33(1):80-5. PMID: 22134093.
      View in: PubMed
    62. Gupta R, Guptha S, Gupta VP, Agrawal A, Gaur K, Deedwania PC. Twenty-year trends in cardiovascular risk factors in India and influence of educational status. Eur J Prev Cardiol. 2012 Dec; 19(6):1258-71. PMID: 21947630.
      View in: PubMed
    63. Roy B, Pawar PP, Desai RV, Fonarow GC, Mujib M, Zhang Y, Feller MA, Ovalle F, Aban IB, Love TE, Iskandrian AE, Deedwania P, Ahmed A. A propensity-matched study of the association of diabetes mellitus with incident heart failure and mortality among community-dwelling older adults. Am J Cardiol. 2011 Dec 15; 108(12):1747-53. PMID: 21943936; PMCID: PMC3324944.
    64. Deedwania P. ACP Journal Club. Review: rosiglitazone increases risk for cardiovascular outcomes and mortality compared with pioglitazone in type 2 diabetes. Ann Intern Med. 2011 Aug 16; 155(4):JC2-12. PMID: 21844545.
      View in: PubMed
    65. Deedwania PC, Huang GW. Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation. Am J Cardiovasc Drugs. 2011 Aug 1; 11(4):265-75. PMID: 21740079.
      View in: PubMed
    66. Deedwania PC, Carbajal EV. Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina. Am J Med. 2011 Aug; 124(8):681-8. PMID: 21787900.
      View in: PubMed
    67. Guey LT, Pullinger CR, Ishida BY, O'Connor PM, Zellner C, Francone OL, Laramie JM, Naya-Vigne JM, Siradze KA, Deedwania P, Redberg RF, Frost PH, Seymour AB, Kane JP, Malloy MJ. Relation of increased prebeta-1 high-density lipoprotein levels to risk of coronary heart disease. Am J Cardiol. 2011 Aug 1; 108(3):360-6. PMID: 21757044.
      View in: PubMed
    68. Desai RV, Guichard JL, Mujib M, Ahmed MI, Feller MA, Fonarow GC, Meyer P, Iskandrian AE, Bogaard HJ, White M, Aban IB, Aronow WS, Deedwania P, Waagstein F, Ahmed A. Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving ß-blockers: insights from the BEST trial. Int J Cardiol. 2013 Feb 10; 163(1):61-7. PMID: 21704392; PMCID: PMC3395778.
    69. Deedwania PC. Blood pressure control in diabetes mellitus: is lower always better, and how low should it go? Circulation. 2011 Jun 21; 123(24):2776-8. PMID: 21690500.
      View in: PubMed
    70. Meyer P, Desai RV, Mujib M, Feller MA, Adamopoulos C, Banach M, Lainscak M, Aban I, White M, Aronow WS, Deedwania P, Iskandrian AE, Ahmed A. Right ventricular ejection fraction <20% is an independent predictor of mortality but not of hospitalization in older systolic heart failure patients. Int J Cardiol. 2012 Feb 23; 155(1):120-5. PMID: 21664707; PMCID: PMC3640328.
    71. Bharani A, Jain N, Jain A, Deedwania P. Endothelium-dependent vasodilation is impaired in healthy offspring of hypertensive parents. Indian Heart J. 2011 May-Jun; 63(3):255-8. PMID: 22734346.
      View in: PubMed
    72. Deedwania PC, Ahmed MI, Feller MA, Aban IB, Love TE, Pitt B, Ahmed A. Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure. Eur J Heart Fail. 2011 May; 13(5):551-9. PMID: 21393298; PMCID: PMC3079464.
    73. Fonseca V, Sharma PP, Shah M, Deedwania P. Risk of new-onset diabetes mellitus associated with beta-blocker treatment for hypertension. Curr Med Res Opin. 2011 Apr; 27(4):799-807. PMID: 21306286.
      View in: PubMed
    74. Banach M, Bhatia V, Feller MA, Mujib M, Desai RV, Ahmed MI, Guichard JL, Aban I, Love TE, Aronow WS, White M, Deedwania P, Fonarow G, Ahmed A. Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure. Am J Cardiol. 2011 Apr 15; 107(8):1208-14. PMID: 21296319; PMCID: PMC3072746.
    75. Lardizabal JA, Deedwania P. Lipid-lowering therapy with statins for the primary and secondary prevention of cardiovascular disease. Cardiol Clin. 2011 Feb; 29(1):87-103. PMID: 21257102.
      View in: PubMed
    76. Deedwania P. Preface cardiovascular disease prevention: the continuum of primary and secondary prevention. Cardiol Clin. 2011 Feb; 29(1):xi-xiii. PMID: 21257096.
      View in: PubMed
    77. Gupta R, Deedwania P. Interventions for cardiovascular disease prevention. Cardiol Clin. 2011 Feb; 29(1):15-34. PMID: 21257098.
      View in: PubMed
    78. Srikanth S, Deedwania P. Primary and secondary prevention strategy for cardiovascular disease in diabetes mellitus. Cardiol Clin. 2011 Feb; 29(1):47-70. PMID: 21257100.
      View in: PubMed
    79. Lardizabal JA, Deedwania PC. The anti-ischemic and anti-anginal properties of statins. Curr Atheroscler Rep. 2011 Feb; 13(1):43-50. PMID: 21107759; PMCID: PMC3018271.
    80. Javed U, Deedwania PC, Bhatt DL, Cannon CP, Dai D, Hernandez A, Peterson ED, Fonarow GC. Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: An analysis of 65,396 hospitalizations from 344 hospita participating in Get With The Guidelines (GWTG). Am Heart J. 2011 Feb; 161(2):418-424.e1-3. PMID: 21404720.
      View in: PubMed
    81. Carbajal EV, Deedwania P. Role of medical versus interventional strategies to prevent coronary events in patients with stable coronary artery disease. Cardiol Clin. 2011 Feb; 29(1):157-65. PMID: 21257106.
      View in: PubMed
    82. Vijayaraghavan K, Deedwania P. Renin-angiotensin-aldosterone blockade for cardiovascular disease prevention. Cardiol Clin. 2011 Feb; 29(1):137-56. PMID: 21257105.
      View in: PubMed
    83. Mujib M, Desai RV, Ahmed MI, Guichard JL, Feller MA, Ekundayo OJ, Deedwania P, Ali M, Aban IB, Love TE, White M, Aronow WS, Rahimtoola SH, Bonow RO, Ahmed A. Rheumatic heart disease and risk of incident heart failure among community-dwelling older adults: a prospective cohort study. Ann Med. 2012 May; 44(3):253-61. PMID: 21254894; PMCID: PMC3116996.
    84. Arsenault BJ, Barter P, DeMicco DA, Bao W, Preston GM, LaRosa JC, Grundy SM, Deedwania P, Greten H, Wenger NK, Shepherd J, Waters DD, Kastelein JJ. Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers. J Am Coll Cardiol. 2011 Jan 4; 57(1):63-9. PMID: 21185503.
      View in: PubMed
    85. Mujib M, Rahman AA, Desai RV, Ahmed MI, Feller MA, Aban I, Love TE, White M, Deedwania P, Aronow WS, Fonarow G, Ahmed A. Warfarin use and outcomes in patients with advanced chronic systolic heart failure without atrial fibrillation, prior thromboembolic events, or prosthetic valves. Am J Cardiol. 2011 Feb 15; 107(4):552-7. PMID: 21185004; PMCID: PMC3053576.
    86. Javed U, Deedwania PC, Bhatt DL, Cannon CP, Dai D, Hernandez AF, Peterson ED, Fonarow GC. Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG). Am Heart J. 2010 Dec; 160(6):1130-6, 1136.e1-3. PMID: 21146668.
      View in: PubMed
    87. Deedwania P. Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating ß-blockers. J Clin Hypertens (Greenwich). 2011 Jan; 13(1):52-9. PMID: 21214722.
      View in: PubMed
    88. Lardizabal JA, Deedwania PC. The role of renin-angiotensin agents in altering the natural history of type 2 diabetes mellitus. Curr Cardiol Rep. 2010 Nov; 12(6):464-71. PMID: 20809236; PMCID: PMC2939350.
    89. Singh V, Sharma R, Kumar A, Deedwania P. Low high-density lipoprotein cholesterol: current status and future strategies for management. Vasc Health Risk Manag. 2010; 6:979-96. PMID: 21127701; PMCID: PMC2988622.
    90. Ahmed MI, Mujib M, Desai RV, Feller MA, Daniel C, Aban IB, Love TE, Deedwania P, Pitt B, Aronow WS, Ahmed A. Outcomes in younger and older adults with chronic advanced systolic heart failure: a propensity-matched study. Int J Cardiol. 2012 Jan 26; 154(2):128-33. PMID: 20947188; PMCID: PMC3116091.
    91. Adamopoulos C, Meyer P, Desai RV, Karatzidou K, Ovalle F, White M, Aban I, Love TE, Deedwania P, Anker SD, Ahmed A. Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study. Eur J Heart Fail. 2011 Feb; 13(2):200-6. PMID: 20930001; PMCID: PMC3025667.
    92. Lardizabal JA, Deedwania PC. Benefits of statin therapy and compliance in high risk cardiovascular patients. Vasc Health Risk Manag. 2010; 6:843-53. PMID: 20957130; PMCID: PMC2952453.
    93. Deedwania PC. Risk of diabetes and cardiovascular disease: best to return back to the basics: comment on "Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus". Arch Intern Med. 2010 Sep 27; 170(17):1575-7. PMID: 20876409.
      View in: PubMed
    94. Srikanth S, Deedwania P. Hypertension as a cardiometabolic risk. Indian Heart J. 2010 Sep-Oct; 62(5):394-401. PMID: 23189879.
      View in: PubMed
    95. Sowers JR, Raij L, Jialal I, Egan BM, Ofili EO, Samuel R, Zappe DH, Purkayastha D, Deedwania PC. Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives. J Hypertens. 2010 Aug; 28(8):1761-9. PMID: 20498618; PMCID: PMC2908201.
    96. Desai RV, Banach M, Ahmed MI, Mujib M, Aban I, Love TE, White M, Fonarow G, Deedwania P, Aronow WS, Ahmed A. Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial). Am J Cardiol. 2010 Jul 15; 106(2):221-7. PMID: 20599007; PMCID: PMC2945308.
    97. Ho JE, Bittner V, Demicco DA, Breazna A, Deedwania PC, Waters DD. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial). Am J Cardiol. 2010 Apr 1; 105(7):905-11. PMID: 20346304.
      View in: PubMed
    98. Holman RR, Haffner SM, McMurray JJ, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR, Gaciong Z, Gaztambide S, Giles T, Horton E, Ilkova H, Jenssen T, Kahn SE, Krum H, Laakso M, Leiter LA, Levitt NS, Mareev V, Martinez F, Masson C, Mazzone T, Meaney E, Nesto R, Pan C, Prager R, Raptis SA, Rutten GE, Sandstroem H, Schaper F, Scheen A, Schmitz O, Sinay I, Soska V, Stender S, Tamás G, Tognoni G, Tuomilehto J, Villamil AS, Vozár J, Califf RM. Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med. 2010 Apr 22; 362(16):1463-76. PMID: 20228402.
      View in: PubMed
    99. McMurray JJ, Holman RR, Haffner SM, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR, Gaciong Z, Gaztambide S, Giles T, Horton E, Ilkova H, Jenssen T, Kahn SE, Krum H, Laakso M, Leiter LA, Levitt NS, Mareev V, Martinez F, Masson C, Mazzone T, Meaney E, Nesto R, Pan C, Prager R, Raptis SA, Rutten GE, Sandstroem H, Schaper F, Scheen A, Schmitz O, Sinay I, Soska V, Stender S, Tamás G, Tognoni G, Tuomilehto J, Villamil AS, Vozár J, Califf RM. Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med. 2010 Apr 22; 362(16):1477-90. PMID: 20228403.
      View in: PubMed
    100. Deedwania PC, Lardizabal JA. Atrial fibrillation in heart failure: a comprehensive review. Am J Med. 2010 Mar; 123(3):198-204. PMID: 20193823.
      View in: PubMed
    101. Lardizabal JA, Deedwania PC. The current state of beta blockers in hypertension therapy. Indian Heart J. 2010 Mar-Apr; 62(2):111-7. PMID: 21180299.
      View in: PubMed
    102. Stein PK, Deedwania P. New York Heart Association functional class influences the impact of diabetes on cardiac autonomic function. J Electrocardiol. 2010 Sep-Oct; 43(5):379-84. PMID: 20096854.
      View in: PubMed
    103. LaRosa JC, Deedwania PC, Shepherd J, Wenger NK, Greten H, DeMicco DA, Breazna A. Comparison of 80 versus 10 mg of atorvastatin on occurrence of cardiovascular events after the first event (from the Treating to New Targets [TNT] trial). Am J Cardiol. 2010 Feb 1; 105(3):283-7. PMID: 20102935.
      View in: PubMed
    104. Bethel MA, Deedwania P, Levitt NS, Schmitz O, Huntsman-Labed A, Califf RM, Haffner SM, Diem P. Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population. Diabet Med. 2009 Dec; 26(12):1204-11. PMID: 20002471.
      View in: PubMed
    105. Sharma KK, Gupta R, Agrawal A, Roy S, Kasliwal A, Bana A, Tongia RK, Deedwania PC. Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India. Vasc Health Risk Manag. 2009; 5:1007-14. PMID: 19997570; PMCID: PMC2788593.
    106. Deedwania P, Singh V, Davidson MH. Low high-density lipoprotein cholesterol and increased cardiovascular disease risk: an analysis of statin clinical trials. Am J Cardiol. 2009 Nov 16; 104(10 Suppl):3E-9E. PMID: 19895938.
      View in: PubMed
    107. Javed U, Deedwania PC. Beta-adrenergic blockers for chronic heart failure. Cardiol Rev. 2009 Nov-Dec; 17(6):287-92. PMID: 19829179.
      View in: PubMed
    108. Kosiborod M, Deedwania P. An overview of glycemic control in the coronary care unit with recommendations for clinical management. J Diabetes Sci Technol. 2009 Nov; 3(6):1342-51. PMID: 20144388; PMCID: PMC2787034.
    109. Singh V, Deedwania P. Reducing morbidity and mortality in high risk patients with statins. Vasc Health Risk Manag. 2009; 5(2):495-507. PMID: 19554090; PMCID: PMC2697584.
    110. Stein PK, Deedwania P. Usefulness of abnormal heart rate turbulence to predict cardiovascular mortality in high-risk patients with acute myocardial infarction and left ventricular dysfunction (from the EPHESUS study). Am J Cardiol. 2009 Jun 1; 103(11):1495-9. PMID: 19463505.
      View in: PubMed
    111. Fonarow GC, Deedwania P, Fonseca V, Nesto RW, Watson K, Tarka E, Lukas MA, Madan A, Shabbout M. Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid Trial. J Am Soc Hypertens. 2009 May-Jun; 3(3):210-20. PMID: 20409961.
      View in: PubMed
    112. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol. 2009 Jan 20; 53(3):298-304. PMID: 19147051.
      View in: PubMed
    113. Deedwania PC, Carbajal EV. Getting with the ACC/AHA guidelines for the treatment of chronic angina as a disease state. Rev Cardiovasc Med. 2009; 10 Suppl 1:S11-20. PMID: 19898283.
      View in: PubMed
    114. Deedwania P. Contemporary approaches for cardiovascular risk reduction in diabetes. Indian Heart J. 2009 Jan-Feb; 61(1):24-33. PMID: 19729685.
      View in: PubMed
    115. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Circulation. 2009 Jan 20; 119(2):351-7. PMID: 19095622.
      View in: PubMed
    116. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009 Jan; 32(1):187-92. PMID: 19092168; PMCID: PMC2606812.
    117. Zappe DH, Sowers JR, Hsueh WA, Haffner SM, Deedwania PC, Fonseca VA, Keeling L, Sica DA. Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome. J Clin Hypertens (Greenwich). 2008 Dec; 10(12):894-903. PMID: 19120715.
      View in: PubMed
    118. Javed U, Deedwania PC. Angiotensin receptor blockers: novel role in high-risk patients. Cardiol Clin. 2008 Nov; 26(4):507-26. PMID: 18929228.
      View in: PubMed
    119. Deedwania PC, Javed U. Statins in heart failure. Cardiol Clin. 2008 Nov; 26(4):573-87. PMID: 18929232.
      View in: PubMed
    120. Sachdeva A, Cannon CP, Deedwania PC, Labresh KA, Smith SC, Dai D, Hernandez A, Fonarow GC. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J. 2009 Jan; 157(1):111-117.e2. PMID: 19081406.
      View in: PubMed
    121. Deedwania P. The endocannabinoid system and cardiometabolic risk: effects of CB1 receptor blockade on lipid metabolism. Int J Cardiol. 2009 Jan 24; 131(3):305-12. PMID: 18715660.
      View in: PubMed
    122. Ram CV, Deedwania PC. Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET? Am J Cardiol. 2008 Nov 1; 102(9):1281-3. PMID: 18940307.
      View in: PubMed
    123. Shepherd J, Kastelein JP, Bittner VA, Carmena R, Deedwania PC, Breazna A, Dobson S, Wilson DJ, Zuckerman AL, Wenger NK. Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease. Mayo Clin Proc. 2008 Aug; 83(8):870-9. PMID: 18674471.
      View in: PubMed
    124. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Anesthesiology. 2008 Jul; 109(1):14-24. PMID: 18580168.
      View in: PubMed
    125. Stein PK, Sanghavi D, Domitrovich PP, Mackey RA, Deedwania P. Ambulatory ECG-based T-wave alternans predicts sudden cardiac death in high-risk post-MI patients with left ventricular dysfunction in the EPHESUS study. J Cardiovasc Electrophysiol. 2008 Oct; 19(10):1037-42. PMID: 18554193.
      View in: PubMed
    126. Kastelein JJ, van der Steeg WA, Holme I, Gaffney M, Cater NB, Barter P, Deedwania P, Olsson AG, Boekholdt SM, Demicco DA, Szarek M, LaRosa JC, Pedersen TR, Grundy SM. Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation. 2008 Jun 10; 117(23):3002-9. PMID: 18519851.
      View in: PubMed
    127. Singh V, Deedwania P. Expanding roles for atorvastatin. Drugs Today (Barc). 2008 Jun; 44(6):455-71. PMID: 18596999.
      View in: PubMed
    128. Kostis JB, Breazna A, Deedwania PC, LaRosa JC. The benefits of intensive lipid lowering in patients with stable coronary heart disease with normal or high systolic blood pressure: an analysis of the Treating to New Targets (TNT) study. J Clin Hypertens (Greenwich). 2008 May; 10(5):367-76. PMID: 18453796.
      View in: PubMed
    129. Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study. J Am Coll Cardiol. 2008 Apr 15; 51(15):1448-54. PMID: 18402899.
      View in: PubMed
    130. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2008 Mar 25; 117(12):1610-9. PMID: 18299505.
      View in: PubMed
    131. Gupta R, Gupta VP, Bhagat N, Rastogi P, Sarna M, Prakash H, Deedwania PC. Obesity is major determinant of coronary risk factors in India: Jaipur Heart Watch studies. Indian Heart J. 2008 Jan-Feb; 60(1):26-33. PMID: 19212018.
      View in: PubMed
    132. Deedwania P, Srikanth S. Diabetes and vascular disease. Expert Rev Cardiovasc Ther. 2008 Jan; 6(1):127-38. PMID: 18095912.
      View in: PubMed
    133. Fraker TD, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, Smith SC, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol. 2007 Dec 4; 50(23):2264-74. PMID: 18061078.
      View in: PubMed
    134. Fraker TD, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, Smith SC, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW. 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina. Circulation. 2007 Dec 4; 116(23):2762-72. PMID: 17998462.
      View in: PubMed
    135. Deedwania P. Evolving treatment options for prevention of cardiovascular events in high-risk hypertensive patients. J Clin Hypertens (Greenwich). 2007 Nov; 9(11):883-8. PMID: 17978596.
      View in: PubMed
    136. Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clin J Am Soc Nephrol. 2007 Nov; 2(6):1131-9. PMID: 17942759.
      View in: PubMed
    137. Ford GA, Choy AM, Deedwania P, Karalis DG, Lindholm CJ, Pluta W, Frison L, Olsson SB. Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation: experience from the SPORTIF III and V Trials. Stroke. 2007 Nov; 38(11):2965-71. PMID: 17885258.
      View in: PubMed
    138. Srikanth S, Deedwania P. Management of coronary artery disease in patients with type 2 diabetes mellitus. Curr Cardiol Rep. 2007 Jul; 9(4):264-71. PMID: 17601392.
      View in: PubMed
    139. Deedwania PC, Gupta M, Stein M, Ycas J, Gold A. Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS Trial). Am J Cardiol. 2007 Jun 1; 99(11):1538-43. PMID: 17531577.
      View in: PubMed
    140. Kosiborod M, Soto GE, Jones PG, Krumholz HM, Weintraub WS, Deedwania P, Spertus JA. Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments. Circulation. 2007 Apr 17; 115(15):1975-81. PMID: 17420346.
      View in: PubMed
    141. Deedwania P, Stone PH, Bairey Merz CN, Cosin-Aguilar J, Koylan N, Luo D, Ouyang P, Piotrowicz R, Schenck-Gustafsson K, Sellier P, Stein JH, Thompson PL, Tzivoni D. Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE). Circulation. 2007 Feb 13; 115(6):700-7. PMID: 17283260.
      View in: PubMed
    142. Deedwania PC, Smith DG. Clinical efficacy and cost-effectiveness of rosuvastatin. Expert Rev Pharmacoecon Outcomes Res. 2007 Feb; 7(1):31-9. PMID: 20528428.
      View in: PubMed
    143. Deedwania PC, Carbajal EV, Bobba VR. Trials and tribulations associated with angina and traditional therapeutic approaches. Clin Cardiol. 2007 Feb; 30(2 Suppl 1):I16-24. PMID: 18373326.
      View in: PubMed
    144. Khush KK, Waters DD, Bittner V, Deedwania PC, Kastelein JJ, Lewis SJ, Wenger NK. Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study. Circulation. 2007 Feb 6; 115(5):576-83. PMID: 17261662.
      View in: PubMed
    145. Stein PK, Tereshchenko L, Domitrovich PP, Kleiger RE, Perez A, Deedwania P. Diastolic dysfunction and autonomic abnormalities in patients with systolic heart failure. Eur J Heart Fail. 2007 Apr; 9(4):364-9. PMID: 17123863.
      View in: PubMed
    146. Deedwania PC, Gupta R. Management issues in the metabolic syndrome. J Assoc Physicians India. 2006 Oct; 54:797-810. PMID: 17214277.
      View in: PubMed
    147. Deedwania P, Barter P, Carmena R, Fruchart JC, Grundy SM, Haffner S, Kastelein JJ, LaRosa JC, Schachner H, Shepherd J, Waters DD. Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study. Lancet. 2006 Sep 9; 368(9539):919-28. PMID: 16962881.
      View in: PubMed
    148. Deedwania PC, Schmieder R. Angiotensin receptor blockers: Cardiovascular protection in the metabolic syndrome. J Renin Angiotensin Aldosterone Syst. 2006 Jun; 7 Suppl 1:S12-8. PMID: 16986230.
      View in: PubMed
    149. Shepherd J, Barter P, Carmena R, Deedwania P, Fruchart JC, Haffner S, Hsia J, Breazna A, LaRosa J, Grundy S, Waters D. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study. Diabetes Care. 2006 Jun; 29(6):1220-6. PMID: 16731999.
      View in: PubMed
    150. Pitt B, Fonarow GC, Gheorghiade M, Deedwania PC, Duprez DA. Improving outcomes in post-acute myocardial infarction heart failure: incorporation of aldosterone blockade into combination therapy to optimize neurohormonal blockade. Am J Cardiol. 2006 May 22; 97(10A):26F-33F. PMID: 16698332.
      View in: PubMed
    151. Deedwania PC, Maki KC, Dicklin MR, Stone NJ, Ballantyne CM, Davidson MH. Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II). J Cardiometab Syndr. 2006; 1(5):295-300. PMID: 17679790.
      View in: PubMed
    152. Singh V, Deedwania P. Dyslipidemia in special populations: Asian Indians, African Americans, and Hispanics. Curr Atheroscler Rep. 2006 Jan; 8(1):32-40. PMID: 16455012.
      View in: PubMed
    153. Caro JJ, Migliaccio-Walle K, O'Brien JA, Nova W, Kim J, Hauch O, Hillson E, Wedel H, Hjalmarson A, Gottlieb S, Deedwania PC, Wikstrand J. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial. J Card Fail. 2005 Dec; 11(9):647-56. PMID: 16360958.
      View in: PubMed
    154. Deedwania P, Singh V. Coronary artery disease in South Asians: evolving strategies for treatment and prevention. Indian Heart J. 2005 Nov-Dec; 57(6):617-31. PMID: 16521627.
      View in: PubMed
    155. Deedwania P. Avoid the rush to judgment in acute coronary syndromes. Postgrad Med. 2005 Sep; 118(3):11-4, 22. PMID: 16201303.
      View in: PubMed
    156. Amsterdam EA, Deedwania P. Bedside evaluation of cardiac markers. Point-of-care testing can differentiate acute coronary syndromes. Postgrad Med. 2005 Sep; 118(3):15-6, 19-22. PMID: 16201304.
      View in: PubMed
    157. Carbajal EV, Deedwania P. Treating non-ST-segment elevation ACS. Pros and cons of current strategies. Postgrad Med. 2005 Sep; 118(3):23-32. PMID: 16201305.
      View in: PubMed
    158. Deedwania PC, Fonseca VA. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm. Am J Med. 2005 Sep; 118(9):939-47. PMID: 16164876.
      View in: PubMed
    159. Davidson MH, Maki KC, Pearson TA, Pasternak RC, Deedwania PC, McKenney JM, Fonarow GC, Maron DJ, Ansell BJ, Clark LT, Ballantyne CM. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. Am J Cardiol. 2005 Aug 15; 96(4):556-63. PMID: 16098311.
      View in: PubMed
    160. Deedwania P. Intensive lipid-lowering is no more effective than diet and low-dose lovastatin for reducing ischaemia in people with heart disease. Commentary. Evid Based Cardiovasc Med. 2005 Sep; 9(3):241-4. PMID: 16380043.
      View in: PubMed
    161. Srikanth S, Deedwania P. Comprehensive risk reduction of cardiovascular risk factors in the diabetic patient: an integrated approach. Cardiol Clin. 2005 May; 23(2):193-210. PMID: 15694747.
      View in: PubMed
    162. Deedwania PC. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy. Cardiol Clin. 2005 May; 23(2):139-52. PMID: 15694743.
      View in: PubMed
    163. Vijayaraghavan K, Deedwania PC. The renin angiotensin system as a therapeutic target to prevent diabetes and its complications. Cardiol Clin. 2005 May; 23(2):165-83. PMID: 15694745.
      View in: PubMed
    164. Deedwania P, Volkova N. Dyslipidemia and lipid-lowering therapy in the elderly. Expert Rev Cardiovasc Ther. 2005 May; 3(3):453-63. PMID: 15889973.
      View in: PubMed
    165. Deedwania PC, Hunninghake DB, Bays HE, Jones PH, Cain VA, Blasetto JW. Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome. Am J Cardiol. 2005 Feb 1; 95(3):360-6. PMID: 15670545.
      View in: PubMed
    166. Gullestad L, Wikstrand J, Deedwania P, Hjalmarson A, Egstrup K, Elkayam U, Gottlieb S, Rashkow A, Wedel H, Bermann G, Kjekshus J. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF). J Am Coll Cardiol. 2005 Jan 18; 45(2):252-9. PMID: 15653024.
      View in: PubMed
    167. Deedwania PC, Giles TD, Klibaner M, Ghali JK, Herlitz J, Hildebrandt P, Kjekshus J, Spinar J, Vitovec J, Stanbrook H, Wikstrand J. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF. Am Heart J. 2005 Jan; 149(1):159-67. PMID: 15660048.
      View in: PubMed
    168. Ghali JK, Dunselman P, Waagstein F, Goldstein S, Gottlieb SS, Deedwania PC, Wikstrand JC. Consistency of the beneficial effect of metoprolol succinate extended release across a wide range dose of angiotensin-converting enzyme inhibitors and digitalis. J Card Fail. 2004 Dec; 10(6):452-9. PMID: 15599834.
      View in: PubMed
    169. Deedwania PC. Effect of aggressive versus moderate lipid-lowering therapy on myocardial ischemia: the rationale, design, and baseline characteristics of the Study Assessing Goals in the Elderly (SAGE). Am Heart J. 2004 Dec; 148(6):1053-9. PMID: 15632893.
      View in: PubMed
    170. Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K. Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol. 2004 Nov; 97(2):257-61. PMID: 15458693.
      View in: PubMed
    171. Mensah GA, Mokdad AH, Ford E, Narayan KM, Giles WH, Vinicor F, Deedwania PC. Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications. Cardiol Clin. 2004 Nov; 22(4):485-504. PMID: 15501618.
      View in: PubMed
    172. Deedwania PC. Diabetes is a vascular disease: the role of endothelial dysfunction in pathophysiology of cardiovascular disease in diabetes. Cardiol Clin. 2004 Nov; 22(4):505-9, v. PMID: 15501619.
      View in: PubMed
    173. Deedwania PC, Davidson MH, Ballantyne CM. Treating dyslipidemia in high-risk patients: case reviews and discussion. Postgrad Med. 2004 Sep; 116(3 Suppl):21-8. PMID: 19667672.
      View in: PubMed
    174. Deedwania PC, Gottlieb S, Ghali JK, Waagstein F, Wikstrand JC. Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure. Eur Heart J. 2004 Aug; 25(15):1300-9. PMID: 15288157.
      View in: PubMed
    175. Deedwania PC, Hunninghake DB, Bays H. Effects of lipid-altering treatment in diabetes mellitus and the metabolic syndrome. Am J Cardiol. 2004 Jun 3; 93(11A):18C-26C. PMID: 15178513.
      View in: PubMed
    176. Deedwania PC. Metabolic syndrome and vascular disease: is nature or nurture leading the new epidemic of cardiovascular disease? Circulation. 2004 Jan 6; 109(1):2-4. PMID: 14707015.
      View in: PubMed
    177. Domanski MJ, Krause-Steinrauf H, Massie BM, Deedwania P, Follmann D, Kovar D, Murray D, Oren R, Rosenberg Y, Young J, Zile M, Eichhorn E. A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS. J Card Fail. 2003 Oct; 9(5):354-63. PMID: 14583895.
      View in: PubMed
    178. Domanski M, Krause-Steinrauf H, Deedwania P, Follmann D, Ghali JK, Gilbert E, Haffner S, Katz R, Lindenfeld J, Lowes BD, Martin W, McGrew F, Bristow MR. The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. J Am Coll Cardiol. 2003 Sep 3; 42(5):914-22. PMID: 12957443.
      View in: PubMed
    179. Wikstrand J, Wedel H, Ghali J, Deedwania P, Fagerberg B, Goldstein S, Gottlieb S, Hjalmarson A, Kjekshus J, Waagstein F. How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Card Electrophysiol Rev. 2003 Sep; 7(3):264-75. PMID: 14739726.
      View in: PubMed
    180. Goldstein S, Deedwania P, Gottlieb S, Wikstrand J. Metoprolol CR/XL in black patients with heart failure (from the Metoprolol CR/XL randomized intervention trial in chronic heart failure). Am J Cardiol. 2003 Aug 15; 92(4):478-80. PMID: 12914886.
      View in: PubMed
    181. Deedwania PC. Mechanisms of endothelial dysfunction in the metabolic syndrome. Curr Diab Rep. 2003 Aug; 3(4):289-92. PMID: 12866990.
      View in: PubMed
    182. Gupta R, Sharma AK, Gupta VP, Bhatnagar S, Rastogi S, Deedwania PC. Increased variance in blood pressure distribution and changing hypertension prevalence in an urban Indian population. J Hum Hypertens. 2003 Aug; 17(8):535-40. PMID: 12874610.
      View in: PubMed
    183. Ravnan SL, Deedwania PC. The rational use of diuretics in heart failure. Curr Cardiol Rep. 2003 May; 5(3):237-42. PMID: 12691643.
      View in: PubMed
    184. Deedwania PC. The key to unraveling the mystery of mortality in heart failure: an integrated approach. Circulation. 2003 Apr 8; 107(13):1719-21. PMID: 12682028.
      View in: PubMed
    185. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, Gibbons RJ, Alpert JS, Antman EM, Hiratzka LF, Fuster V, Faxon DP, Gregoratos G, Jacobs AK, Smith SC. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation. 2003 Jan 7; 107(1):149-58. PMID: 12515758.
      View in: PubMed
    186. Deedwania PC. Diabetes and vascular disease: common links in the emerging epidemic of coronary artery disease. Am J Cardiol. 2003 Jan 1; 91(1):68-71. PMID: 12505574.
      View in: PubMed
    187. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol. 2003 Jan 1; 41(1):159-68. PMID: 12570960.
      View in: PubMed
    188. Deedwania PC. Heart failure in the elderly: is beta-blockade the standard of care? Postgrad Med. 2002 Dec; 112(6 Suppl Heart):21-7. PMID: 19667614.
      View in: PubMed
    189. Matalka MS, Ravnan MC, Deedwania PC. Is alternate daily dose of atorvastatin effective in treating patients with hyperlipidemia? The Alternate Day Versus Daily Dosing of Atorvastatin Study (ADDAS). Am Heart J. 2002 Oct; 144(4):674-7. PMID: 12360164.
      View in: PubMed
    190. Khand AU, Cleland JG, Deedwania PC. Prevention of and medical therapy for atrial arrhythmias in heart failure. Heart Fail Rev. 2002 Jul; 7(3):267-83. PMID: 12215732.
      View in: PubMed
    191. Reynolds HQ, Deedwania PC. Treating hypertension in patients with diabetes. Nurse Pract. 2002 Jul; 27(7):11-21; quiz 21-3. PMID: 12131797.
      View in: PubMed
    192. Kerensky RA, Wade M, Deedwania P, Boden WE, Pepine CJ. Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory. J Am Coll Cardiol. 2002 May 1; 39(9):1456-63. PMID: 11985907.
      View in: PubMed
    193. Ghali JK, Piña IL, Gottlieb SS, Deedwania PC, Wikstrand JC. Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Circulation. 2002 Apr 2; 105(13):1585-91. PMID: 11927527.
      View in: PubMed
    194. Spertus JA, Tooley J, Jones P, Poston C, Mahoney E, Deedwania P, Hurley S, Pitt B, Weintraub WS. Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone's neuroHormonal Efficacy and SUrvival Study). Am Heart J. 2002 Apr; 143(4):636-42. PMID: 11923800.
      View in: PubMed
    195. Gottlieb SS, Fisher ML, Kjekshus J, Deedwania P, Gullestad L, Vitovec J, Wikstrand J. Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Circulation. 2002 Mar 12; 105(10):1182-8. PMID: 11889011.
      View in: PubMed
    196. Deedwania PC. The changing face of hypertension: is systolic blood pressure the final answer? Arch Intern Med. 2002 Mar 11; 162(5):506-8. PMID: 11871917.
      View in: PubMed
    197. Ravnan SL, Ravnan MC, Deedwania PC. Pharmacotherapy in congestive heart failure: diuretic resistance and strategies to overcome resistance in patients with congestive heart failure. Congest Heart Fail. 2002 Mar-Apr; 8(2):80-5. PMID: 11927781.
      View in: PubMed
    198. Deedwania PC. Pharmacotherapy of hypertension in patients with diabetes mellitus. Expert Opin Pharmacother. 2001 Nov; 2(11):1805-16. PMID: 11825318.
      View in: PubMed
    199. Deedwania PC, Stone PH. Ambulatory electrocardiographic monitoring for myocardial ischemia. Curr Probl Cardiol. 2001 Nov; 26(11):680-727. PMID: 11677468.
      View in: PubMed
    200. Deedwania P. Global risk assessment in the presymptomatic patient. Am J Cardiol. 2001 Oct 11; 88(7B):17J-22J. PMID: 11595194.
      View in: PubMed
    201. Perkiömäki JS, Zareba W, Ruta J, Dubner S, Madoery C, Deedwania P, Karcz M, Bayes de Luna A. Fractal and complexity measures of heart rate dynamics after acute myocardial infarction. Am J Cardiol. 2001 Oct 1; 88(7):777-81. PMID: 11589848.
      View in: PubMed
    202. Wedel H, Demets D, Deedwania P, Fagerberg B, Goldstein S, Gottlieb S, Hjalmarson A, Kjekshus J, Waagstein F, Wikstrand J. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial. Am Heart J. 2001 Sep; 142(3):502-11. PMID: 11526365.
      View in: PubMed
    203. Deedwania PC. Silent ischemia predicts poor outcome in high-risk healthy men. J Am Coll Cardiol. 2001 Jul; 38(1):80-3. PMID: 11451300.
      View in: PubMed
    204. Sun YP, Zhu BQ, Browne AE, Pulukurthy S, Chou TM, Sudhir K, Glantz SA, Deedwania PC, Chatterjee K, Parmley WW. Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function. J Cardiovasc Pharmacol Ther. 2001 Apr; 6(2):175-81. PMID: 11509924.
      View in: PubMed
    205. Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ, McNamara JR, Kashyap ML, Hershman JM, Wexler LF, Rubins HB. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA. 2001 Mar 28; 285(12):1585-91. PMID: 11268266.
      View in: PubMed
    206. Chandalia M, Deedwania PC. Coronary heart disease and risk factors in Asian Indians. Adv Exp Med Biol. 2001; 498:27-34. PMID: 11900378.
      View in: PubMed
    207. Heggunje PS, Wade MJ, O'Rourke RA, Kleiger RE, Deedwania PC, Lavori PW, Boden WE. Early invasive versus ischaemia-guided strategies in the management of non-Q wave myocardial infarction patients with and without prior myocardial infarction; results of Veterans Affairs Non-Q Wave Infarction Strategies in Hospital (VANQWISH) trial. Eur Heart J. 2000 Dec; 21(24):2014-25. PMID: 11102252.
      View in: PubMed
    208. Deedwania PC. Mechanism of the deadly quartet. Can J Cardiol. 2000 Aug; 16 Suppl E:17E-20E. PMID: 10906620.
      View in: PubMed
    209. Deedwania PC. Hypertension and diabetes: new therapeutic options. Arch Intern Med. 2000 Jun 12; 160(11):1585-94. PMID: 10847251.
      View in: PubMed
    210. Deedwania PC. Hypercholesterolemia. Is lipid-lowering worthwhile for older patients? Geriatrics. 2000 May; 55(5):22-8. PMID: 10826262.
      View in: PubMed
    211. Deedwania PC. Silent myocardial ischaemia in the elderly. Drugs Aging. 2000 May; 16(5):381-9. PMID: 10917075.
      View in: PubMed
    212. Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, Wikstrand J, El Allaf D, Vítovec J, Aldershvile J, Halinen M, Dietz R, Neuhaus KL, Jánosi A, Thorgeirsson G, Dunselman PH, Gullestad L, Kuch J, Herlitz J, Rickenbacher P, Ball S, Gottlieb S, Deedwania P. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA. 2000 Mar 8; 283(10):1295-302. PMID: 10714728.
      View in: PubMed
    213. Wong M, Germanson T, Taylor WR, Cohen IS, Perry G, Baruch L, Deedwania P, Lopez B, Cohn JN. Felodipine improves left ventricular emptying in patients with chronic heart failure: V-HeFT III echocardiographic substudy of multicenter reproducibility and detecting functional change. J Card Fail. 2000 Mar; 6(1):19-28. PMID: 10746815.
      View in: PubMed
    214. Deedwania PC. Endothelium: a new target for cardiovascular therapeutics. J Am Coll Cardiol. 2000 Jan; 35(1):67-70. PMID: 10636261.
      View in: PubMed
    215. Crawford MH, Bernstein SJ, Deedwania PC, DiMarco JP, Ferrick KJ, Garson A, Green LA, Greene HL, Silka MJ, Stone PH, Tracy CM, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Gregoratos G, Russell RO, Ryan TH, Smith SC. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology. J Am Coll Cardiol. 1999 Sep; 34(3):912-48. PMID: 10483977.
      View in: PubMed
    216. Crawford MH, Bernstein SJ, Deedwania PC, DiMarco JP, Ferrick KJ, Garson A, Green LA, Greene HL, Silka MJ, Stone PH, Tracy CM, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Gregoratos G, Russell RO, Ryan TJ, Smith SC. ACC/AHA guidelines for ambulatory electrocardiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the guidelines for ambulatory electrocardiography). Circulation. 1999 Aug 24; 100(8):886-93. PMID: 10458728.
      View in: PubMed
    217. Hutchison SJ, Sudhir K, Sievers RE, Zhu BQ, Sun YP, Chou TM, Chatterjee K, Deedwania PC, Cooke JP, Glantz SA, Parmley WW. Effects of L-arginine on atherogenesis and endothelial dysfunction due to secondhand smoke. Hypertension. 1999 Jul; 34(1):44-50. PMID: 10406822.
      View in: PubMed
    218. Gradman AH, Lewin A, Bowling BT, Tonkon M, Deedwania PC, Kezer AE, Hardison JD, Cushing DJ, Michelson EL. Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study Group. Heart Dis. 1999 May-Jun; 1(2):52-7. PMID: 11720604.
      View in: PubMed
    219. Deedwania PC. Anti-ischemic effects of amlodipine in patients with stable angina pectoris and myocardial ischemia during daily life. Amlodipine Study Group. Am J Cardiol. 1999 Apr 1; 83(7):1117-9, A8-9. PMID: 10190530.
      View in: PubMed
    220. Deedwania PC. Endothelin, the bad actor in the play: a marker or mediator of cardiovascular disease. J Am Coll Cardiol. 1999 Mar 15; 33(4):939-42. PMID: 10091819.
      View in: PubMed
    221. Frishman WH, Glasser S, Stone P, Deedwania PC, Johnson M, Fakouhi TD. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris. Am J Cardiol. 1999 Feb 15; 83(4):507-14. PMID: 10073852.
      View in: PubMed
    222. Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R, Singh SN. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. Circulation. 1998 Dec 8; 98(23):2574-9. PMID: 9843465.
      View in: PubMed
    223. Pepine CJ, Deedwania PC. How do we best treat patients with ischemic heart disease? Circulation. 1998 Nov 10; 98(19):1985-6. PMID: 9808592.
      View in: PubMed
    224. Hutchison SJ, Glantz SA, Zhu BQ, Sun YP, Chou TM, Chatterjee K, Deedwania PC, Parmley WW, Sudhir K. In-utero and neonatal exposure to secondhand smoke causes vascular dysfunction in newborn rats. J Am Coll Cardiol. 1998 Nov; 32(5):1463-7. PMID: 9809964.
      View in: PubMed
    225. Moon MR, Fann JI, Deedwania PC, Ferguson R, Kosek JC, Burdon TA. Tophaceous pseudogout of the mitral valve. Ann Thorac Surg. 1998 Sep; 66(3):952-4. PMID: 9768968.
      View in: PubMed
    226. Criqui MH, Kinosian B, Glick H, Deedwania PC, Krauss RM. The American College of Physicians guidelines for screening blood cholesterol levels: a commentary. Am J Med. 1998 Jul 6; 105(1A):75S-76S. PMID: 9707272.
      View in: PubMed
    227. Deedwania PC. The deadly quartet revisited. Am J Med. 1998 Jul 6; 105(1A):1S-3S. PMID: 9707261.
      View in: PubMed
    228. Amsterdam EA, Deedwania PC. A perspective on hyperlipidemia: concepts of management in the prevention of coronary artery disease. Am J Med. 1998 Jul 6; 105(1A):69S-74S. PMID: 9707271.
      View in: PubMed
    229. Fagan TC, Deedwania PC. The cardiovascular dysmetabolic syndrome. Am J Med. 1998 Jul 6; 105(1A):77S-82S. PMID: 9707273.
      View in: PubMed
    230. Boden WE, O'Rourke RA, Crawford MH, Blaustein AS, Deedwania PC, Zoble RG, Wexler LF, Kleiger RE, Pepine CJ, Ferry DR, Chow BK, Lavori PW. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med. 1998 Jun 18; 338(25):1785-92. PMID: 9632444.
      View in: PubMed
    231. Schwarzacher SP, Hutchison S, Chou TM, Sun YP, Zhu BQ, Chatterjee K, Glantz SA, Deedwania PC, Parmley WW, Sudhir K. Antioxidant diet preserves endothelium-dependent vasodilatation in resistance arteries of hypercholesterolemic rabbits exposed to environmental tobacco smoke. J Cardiovasc Pharmacol. 1998 May; 31(5):649-53. PMID: 9593062.
      View in: PubMed
    232. Sun YP, Zhu BQ, Sievers RE, Norkus EP, Parmley WW, Deedwania PC. Effects of antioxidant vitamins C and E on atherosclerosis in lipid-fed rabbits. Cardiology. 1998 Mar; 89(3):189-94. PMID: 9570433.
      View in: PubMed
    233. Ferry DR, O'Rourke RA, Blaustein AS, Crawford MH, Deedwania PC, Carson PE, Pepine CJ, Thomas RG, Hlatky MA, Leppo JA, Iwane MK, Kleiger RE, Zoble RG, Dai H, Chow BK, Lavori PW, Boden WE. Design and baseline characteristics of the Veterans Affairs Non-Q-Wave Infarction Strategies In-Hospital (VANQWISH) trial. VANQWISH Trial Research Investigators. J Am Coll Cardiol. 1998 Feb; 31(2):312-20. PMID: 9462573.
      View in: PubMed
    234. Zhu BQ, Sun YP, Sudhir K, Sievers RE, Browne AE, Gao L, Hutchison SJ, Chou TM, Deedwania PC, Chatterjee K, Glantz SA, Parmley WW. Effects of second-hand smoke and gender on infarct size of young rats exposed in utero and in the neonatal to adolescent period. J Am Coll Cardiol. 1997 Dec; 30(7):1878-85. PMID: 9385922.
      View in: PubMed
    235. Deedwania PC. Underutilization of evidence-based therapy in heart failure. An opportunity to deal a winning hand with ace up your sleeve. Arch Intern Med. 1997 Nov 24; 157(21):2409-12. PMID: 9385293.
      View in: PubMed
    236. Deedwania PC, Carbajal EV. Role of beta blockade in the treatment of myocardial ischemia. Am J Cardiol. 1997 Nov 13; 80(9B):23J-28J. PMID: 9375946.
      View in: PubMed
    237. Muller JE, Kaufmann PG, Luepker RV, Weisfeldt ML, Deedwania PC, Willerson JT. Mechanisms precipitating acute cardiac events: review and recommendations of an NHLBI workshop. National Heart, Lung, and Blood Institute. Mechanisms Precipitating Acute Cardiac Events Participants. Circulation. 1997 Nov 4; 96(9):3233-9. PMID: 9386197.
      View in: PubMed
    238. Deedwania PC. The progression from hypertension to heart failure. Am J Hypertens. 1997 Oct; 10(10 Pt 2):280S-288S. PMID: 9366285.
      View in: PubMed
    239. Ginier P, Deedwania P. Lipoprotein(a) in patients who have non-insulin-dependent diabetes with and without coronary artery disease. Endocr Pract. 1997 Sep-Oct; 3(5):276-80. PMID: 15251780.
      View in: PubMed
    240. Deedwania PC, Pool PE, Thadani U, Eff J. Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. Dilacor XR Ambulatory Ischemia Study Group. Am J Cardiol. 1997 Aug 15; 80(4):421-5. PMID: 9285652.
      View in: PubMed
    241. Singh SN, Fisher SG, Deedwania PC, Rohatgi P, Singh BN, Fletcher RD. Pulmonary effect of amiodarone in patients with heart failure. The Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy (CHF-STAT) Investigators (Veterans Affairs Cooperative Study No. 320). J Am Coll Cardiol. 1997 Aug; 30(2):514-7. PMID: 9247526.
      View in: PubMed
    242. Deedwania PC, Carbajal EV. Can ambulatory monitoring identify high-risk patients with stable coronary artery disease? JAMA. 1997 Jun 11; 277(22):1760-1. PMID: 9178784.
      View in: PubMed
    243. Hutchison SJ, Reitz MS, Sudhir K, Sievers RE, Zhu BQ, Sun YP, Chou TM, Deedwania PC, Chatterjee K, Glantz SA, Parmley WW. Chronic dietary L-arginine prevents endothelial dysfunction secondary to environmental tobacco smoke in normocholesterolemic rabbits. Hypertension. 1997 May; 29(5):1186-91. PMID: 9149685.
      View in: PubMed
    244. Deedwania PC. Clinical relevance of ischemia induced by mental stress. Clin Cardiol. 1997 Apr; 20(4):317-9. PMID: 9098587.
      View in: PubMed
    245. Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) Lancet. 1997 Mar 15; 349(9054):747-52. PMID: 9074572.
      View in: PubMed
    246. Hutchison SJ, Sudhir K, Chou TM, Sievers RE, Zhu BQ, Sun YP, Deedwania PC, Glantz SA, Parmley WW, Chatterjee K. Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta. J Am Coll Cardiol. 1997 Mar 15; 29(4):800-7. PMID: 9091527.
      View in: PubMed
    247. Deedwania PC, Amsterdam EA, Vagelos RH. Evidence-based, cost-effective risk stratification and management after myocardial infarction. California Cardiology Working Group on Post-MI Management. Arch Intern Med. 1997 Feb 10; 157(3):273-80. PMID: 9040293.
      View in: PubMed
    248. Deedwania PC. Silent ischaemia: to treat or not to treat? Indian Heart J. 1996 Jul-Aug; 48(4):415-9. PMID: 8908836.
      View in: PubMed
    249. Massie BM, Fisher SG, Radford M, Deedwania PC, Singh BN, Fletcher RD, Singh SN. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators. Circulation. 1996 Jun 15; 93(12):2128-34. PMID: 8925581.
      View in: PubMed
    250. Deedwania PC. Hemodynamic changes as triggers of cardiovascular events. Cardiol Clin. 1996 May; 14(2):229-38. PMID: 8724555.
      View in: PubMed
    251. Deedwania PC. Anti-ischemic properties of ACE-inhibitors. Cardiologia. 1996 Mar; 41(3):209-15. PMID: 8697478.
      View in: PubMed
    252. Deedwania PC. Hemodynamic variability and myocardial ischemia. Cardiol Clin. 1995 Nov; 13(4):491-500. PMID: 8565012.
      View in: PubMed
    253. Carbajal EV, Deedwania PC. Contemporary approaches in medical management of patients with stable coronary artery disease. Med Clin North Am. 1995 Sep; 79(5):1063-84. PMID: 7674685.
      View in: PubMed
    254. Deedwania PC. Clinical perspectives on primary and secondary prevention of coronary atherosclerosis. Med Clin North Am. 1995 Sep; 79(5):973-98. PMID: 7674695.
      View in: PubMed
    255. Deedwania PC. Early intervention in patients with heart failure and left ventricular dysfunction. Med Clin North Am. 1995 Sep; 79(5):1191-203. PMID: 7674691.
      View in: PubMed
    256. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med. 1995 Jul 13; 333(2):77-82. PMID: 7539890.
      View in: PubMed
    257. Deedwania PC. Mental stress, pain perception and risk of silent ischemia. J Am Coll Cardiol. 1995 Jun; 25(7):1504-6. PMID: 7759698.
      View in: PubMed
    258. Deedwania PC. The need for a cost-effective strategy to detect ambulatory silent ischemia. Am J Cardiol. 1994 Nov 15; 74(10):1061-2. PMID: 7977048.
      View in: PubMed
    259. Deedwania PC. Triggers and timing of coronary events and sudden cardiac death. J Am Coll Cardiol. 1994 Oct; 24(4):968-71. PMID: 7930232.
      View in: PubMed
    260. Pepine CJ, Cohn PF, Deedwania PC, Gibson RS, Handberg E, Hill JA, Miller E, Marks RG, Thadani U. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST) Circulation. 1994 Aug; 90(2):762-8. PMID: 8044945.
      View in: PubMed
    261. Deedwania PC. Is there evidence in support of the ischemia suppression hypothesis? J Am Coll Cardiol. 1994 Jul; 24(1):21-4. PMID: 8006267.
      View in: PubMed
    262. Deedwania PC. Should asymptomatic subjects with silent ischemia undergo further evaluation and follow-up? Int J Cardiol. 1994 Mar 15; 44(1):101-3. PMID: 8021044.
      View in: PubMed
    263. Deedwania PC. Comparison of the prognostic values of ischemia during daily life and ischemia induced by treadmill exercise testing. Am J Cardiol. 1994 Mar 10; 73(6):15B-18B. PMID: 8141074.
      View in: PubMed
    264. Deedwania PC. Prevalence and prognosis of heart failure. Cardiol Clin. 1994 Feb; 12(1):1-8. PMID: 8181018.
      View in: PubMed
    265. Deedwania PC. Ventricular arrhythmias in heart failure: to treat or not to treat? Cardiol Clin. 1994 Feb; 12(1):115-32. PMID: 8181020.
      View in: PubMed
    266. Deedwania PC. Prevention of heart failure and postinfarction remodeling. Cardiol Clin. 1994 Feb; 12(1):155-64. PMID: 8181022.
      View in: PubMed
    267. Gradman AH, Deedwania PC. Predictors of mortality in patients with heart failure. Cardiol Clin. 1994 Feb; 12(1):25-35. PMID: 8181023.
      View in: PubMed
    268. Deedwania PC. Does myocardial ischemia portend poor prognosis? J Am Coll Cardiol. 1994 Jan; 23(1):229-32. PMID: 8277086.
      View in: PubMed
    269. Hudson DL, Cohen ME, Deedwania PC. Information integration in a decision support system. Proc Annu Symp Comput Appl Med Care. 1994; 1051. PMID: 7949889; PMCID: PMC2247980.
    270. Singh SN, Fletcher RD, Fisher S, Lazzeri D, Deedwania P, Lewis D, Massie B, Singh BN, Colling C. Veterans Affairs congestive heart failure antiarrhythmic trial. CHF STAT Investigators. Am J Cardiol. 1993 Nov 26; 72(16):99F-102F. PMID: 8237838.
      View in: PubMed
    271. Deedwania PC, Cheitlin MD, Das SK, Pool PE, Singh JB, Pasternak RC. Amlodipine once a day in stable angina: double-blind crossover comparison with placebo. Clin Cardiol. 1993 Aug; 16(8):599-602. PMID: 8370191.
      View in: PubMed
    272. Deedwania PC. Increased demand versus reduced supply and the circadian variations in ambulatory myocardial ischemia. Therapeutic implications. Circulation. 1993 Jul; 88(1):328-31. PMID: 8100490.
      View in: PubMed
    273. Deedwania PC. Asymptomatic ischemia during predischarge Holter monitoring predicts poor prognosis in the postinfarction period. Am J Cardiol. 1993 Apr 1; 71(10):859-61. PMID: 8456768.
      View in: PubMed
    274. Deedwania PC, Carbajal EV. Secondary prevention after myocardial infarction. Too many choices, which ones work? Arch Intern Med. 1993 Feb 8; 153(3):285-8. PMID: 8093996.
      View in: PubMed
    275. Jaffe AS, Deedwania PC, Higginson LA, Boden WE, Mehta JL, Ferlinz J, Walsh RA, Sullivan JM, Vokonas PS, Cabin H. Diagnostic and therapeutic implications: exploration through case discussions. Am J Cardiol. 1992 Nov 16; 70(16):45F-48F. PMID: 1442602.
      View in: PubMed
    276. Deedwania P, Schroeder JS, Boden WE. The Council for Myocardial Ischemia and Infarction: advisory group reports on silent myocardial ischemia, heart rate control, and post-myocardial infarction management. Am J Cardiol. 1992 Nov 16; 70(16):39F-44F. PMID: 1442601.
      View in: PubMed
    277. Deedwania P, Carbajal EV. Role of myocardial oxygen demand in the pathogenesis of silent ischemia during daily life. Am J Cardiol. 1992 Nov 16; 70(16):19F-24F. PMID: 1442597.
      View in: PubMed
    278. Deedwania P. Increased myocardial oxygen demand and ischemia during daily life: resurrection of an age-old concept. J Am Coll Cardiol. 1992 Nov 1; 20(5):1099-100. PMID: 1401609.
      View in: PubMed
    279. Singh S, Fletcher RD, Fisher S, Deedwania P, Lewis D, Massie B, Singh B, Colling CL. Congestive heart failure: survival trial of antiarrhythmic therapy (CHF STAT). The CHF STAT Investigators. Control Clin Trials. 1992 Oct; 13(5):339-50. PMID: 1385036.
      View in: PubMed
    280. Deedwania P, Carbajal EV. Ambulatory electrocardiography evaluation of asymptomatic, unstable, and stable coronary artery disease patients for myocardial ischemia. Cardiol Clin. 1992 Aug; 10(3):417-30. PMID: 1504973.
      View in: PubMed
    281. De Marco T, Deedwania P, Chatterjee K. Systemic and coronary hemodynamic effects of bepridil in patients with depressed left ventricular function. Am J Cardiol. 1992 Apr 9; 69(11):31D-36D. PMID: 1553889.
      View in: PubMed
    282. Deedwania P, Carbajal EV. Silent myocardial ischemia. A clinical perspective. Arch Intern Med. 1991 Dec; 151(12):2373-82. PMID: 1746993.
      View in: PubMed
    283. Deedwania P, Carbajal EV. Usefulness of ambulatory silent myocardial ischemia added to the prognostic value of exercise test parameters in predicting risk of cardiac death in patients with stable angina pectoris and exercise-induced myocardial ischemia. Am J Cardiol. 1991 Nov 15; 68(13):1279-86. PMID: 1951112.
      View in: PubMed
    284. Pepine CJ, Cohn PF, Deedwania P, Gibson RS, Gottlieb SO, Handberg E, Hill JA. The prognostic and economic implications of a strategy to detect and treat asymptomatic ischemia: the Atenolol Silent Ischemia Trial (ASIST) protocol. Clin Cardiol. 1991 Jun; 14(6):457-62. PMID: 1810681.
      View in: PubMed
    285. Deedwania P, Carbajal EV, Nelson JR, Hait H. Anti-ischemic effects of atenolol versus nifedipine in patients with coronary artery disease and ambulatory silent ischemia. J Am Coll Cardiol. 1991 Mar 15; 17(4):963-9. PMID: 1999634.
      View in: PubMed
    286. Deedwania P, Carbajal EV. Exercise test predictors of ambulatory silent ischemia during daily life in stable angina pectoris. Am J Cardiol. 1990 Nov 15; 66(17):1151-6. PMID: 2239716.
      View in: PubMed
    287. Deedwania P. Transient myocardial ischemia and its relation to determinants of myocardial oxygen demand. Am J Cardiol. 1990 Nov 6; 66(16):25G-27G. PMID: 2239709.
      View in: PubMed
    288. Deedwania P, Nelson JR. Pathophysiology of silent myocardial ischemia during daily life. Hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring. Circulation. 1990 Oct; 82(4):1296-304. PMID: 1976049.
      View in: PubMed
    289. Deedwania P. Angiotensin-converting enzyme inhibitors in congestive heart failure. Arch Intern Med. 1990 Sep; 150(9):1798-805. PMID: 2132302.
      View in: PubMed
    290. Deedwania P, Carbajal EV. Prevalence and patterns of silent myocardial ischemia during daily life in stable angina patients receiving conventional antianginal drug therapy. Am J Cardiol. 1990 May 1; 65(16):1090-6. PMID: 1970449.
      View in: PubMed
    291. Deedwania P, Carbajal EV. Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation. 1990 Mar; 81(3):748-56. PMID: 2306826.
      View in: PubMed
    292. Deedwania P. Suppressant effects of conventional beta blockers and sotalol on complex and repetitive ventricular premature complexes. Am J Cardiol. 1990 Jan 2; 65(2):43A-50A; discussion 51A-52A. PMID: 1688482.
      View in: PubMed
    293. Deedwania P, Carbajal EV. Is silent myocardial ischemia clinically important? Does it have prognostic significance? Postgrad Med. 1989 Nov 15; 86(7):99-105, 108-10. PMID: 2813229.
      View in: PubMed
    294. Deedwania P, Cheitlin M, Das S, Pool P, Singh J, Pasternak R, Carabello B. Double-blind crossover comparison of amlodipine at three dose levels and placebo in chronic stable angina. Am Heart J. 1989 Nov; 118(5 Pt 2):1132-3. PMID: 2530874.
      View in: PubMed
    295. Gradman A, Deedwania P, Cody R, Massie B, Packer M, Pitt B, Goldstein S. Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. J Am Coll Cardiol. 1989 Sep; 14(3):564-70; discussion 571-2. PMID: 2768707.
      View in: PubMed
    296. Nelson JR, Deedwania P. New exercise parameter for the identification of severe coronary artery disease. Chest. 1989 Apr; 95(4):895-8. PMID: 2924619.
      View in: PubMed
    297. Nguyen NX, Yang PT, Huycke EC, Keung EC, Deedwania P, Sung RJ. Effects of beta-adrenergic stimulation on atrial latency and atrial vulnerability in patients with paroxysmal supraventricular tachycardia. Am J Cardiol. 1988 May 1; 61(13):1031-6. PMID: 3364358.
      View in: PubMed
    298. Nallasivan M, Deedwania PC. Electrophysiologic studies in cardiac arrhythmia. When and why they are useful. Postgrad Med. 1988 Mar; 83(4):197-8, 203-6. PMID: 3353336.
      View in: PubMed
    299. Deedwania PC. Significance of arrhythmias in congestive heart failure. Postgrad Med. 1988 Mar; 83(4):223-5, 228-30. PMID: 3353338.
      View in: PubMed
    300. Mehta J, Lopez LM, Deedwania PC, Fagan TC, Sternlieb CM, Vlachakis ND, Birkett JP, Schwartz LA. Similar efficacy of nitrendipine in young and elderly hypertensive patients. Am J Cardiol. 1987 Nov 1; 60(13):1096-100. PMID: 3314459.
      View in: PubMed
    301. Singh BN, Deedwania P, Nademanee K, Ward A, Sorkin EM. Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use. Drugs. 1987 Sep; 34(3):311-49. PMID: 3315621.
      View in: PubMed
    302. Deedwania P, Olukotun AY, Kupersmith J, Jenkins P, Golden P. Beta blockers in combination with class I antiarrhythmic agents. Am J Cardiol. 1987 Aug 31; 60(6):21D-26D. PMID: 2442991.
      View in: PubMed
    303. Deedwania P, Carbajal EV. Current perspectives in treatment of angina pectoris. Postgrad Med. 1986 Nov 1; 80(6):189-96, 199-204. PMID: 2877451.
      View in: PubMed
    304. Deedwania PC. Silent myocardial ischemia and its relationship to acute myocardial infarction. Cardiol Clin. 1986 Nov; 4(4):643-58. PMID: 3536094.
      View in: PubMed
    305. Fagan TC, Sternleib C, Vlachakis N, Deedwania PC, Mehta JL. Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy. J Cardiovasc Pharmacol. 1984; 6 Suppl 7:S1109-13. PMID: 6085377.
      View in: PubMed
    306. Deedwania PC. Calcium channel blockers. West J Med. 1982 Jul; 137(1):24-31. PMID: 6291255; PMCID: PMC1273979.
    307. Dhingra RC, Wyndham C, Deedwania PC, Bauernfeind R, Swiryn S, Best D, Rosen KM. Effect of age on atrioventricular conduction in patients with chronic bifascicular block. Am J Cardiol. 1980 Apr; 45(4):749-56. PMID: 7361665.
      View in: PubMed
    308. Dhingra RC, Deedwania PC. Significance of fascicular block complicating acute myocardial infarction. Indian Heart J Teach Ser. 1980; (5):159-66. PMID: 7461670.
      View in: PubMed
    309. Deedwania PC, Dhingra RC. Chronic intraventricular conduction defects. Indian Heart J Teach Ser. 1980; (7):343-6. PMID: 7309055.
      View in: PubMed
    310. Dhingra RC, Wyndham C, Bauernfeind R, Swiryn S, Deedwania P, Smith T, Denes P, Rosen KM. Significance of block distal to the His bundle induced by atrial pacing in patients with chronic bifascicular block. Circulation. 1979 Dec; 60(7):1455-64. PMID: 498473.
      View in: PubMed
    311. Deedwania P, Swiryn S, Dhingra RC, Rosen KM. Nocturnal atrioventricular block as a manifestation of sleep apnea syndrome. Chest. 1979 Sep; 76(3):319-21. PMID: 380942.
      View in: PubMed
    312. Wu D, Deedwania P, Dhingra RC, Engleman RM, Rosen KM. Electrophysiologic observations in a patient with bradycardia-dependent atrioventricular block. Am J Cardiol. 1978 Sep; 42(3):506-12. PMID: 685860.
      View in: PubMed
    313. Dhingra RC, Deedwania P, Cummings JM, Amat-Y-Leon F, Wu D, Denes P, Rosen KM. Electrophysiologic effects of lidocaine on sinus node and atrium in patients with and without sinoatrial dysfunction. Circulation. 1978 Mar; 57(3):448-54. PMID: 624154.
      View in: PubMed
    314. Dhingra RC, Amat-y-Leon F, Pietras RJ, Wyndham C, Deedwania PC, Wu D, Denes P, Rosen KM. Sites of conduction disease in aortic stenosis: significance of valve gradient and calcification. Ann Intern Med. 1977 Sep; 87(3):275-80. PMID: 900670.
      View in: PubMed
    315. Amat-y-Leon F, Deedwania P, Miller RH, Dhingra RC, Rosen KM. A new approach for indirect recording of anterior left atrial activation in man. Am Heart J. 1977 Mar; 93(3):408-10. PMID: 842433.
      View in: PubMed
    316. Dhingra RC, Amat-y-Leon F, Wyndham C, Deedwania P, Wu D, Denes P, Rosen KM. Clinical significance of prolonged sinoatrial conduction time. Circulation. 1977 Jan; 55(1):8-15. PMID: 830223.
      View in: PubMed
    Prakash's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP